01 1Bayer AG
01 1Bayer Korea Co., Ltd.
01 1Iopromide
01 1Germany
Registrant Name : Bayer Korea Co., Ltd.
Registration Date : 2018-07-06
Registration Number : 20180706-210-J-240
Manufacturer Name : Bayer AG
Manufacturer Address : Ernst-Schering-Straße 14 59192 Bergkamen Germany
59
PharmaCompass offers a list of Iopromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Iopromide manufacturer or Iopromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iopromide manufacturer or Iopromide supplier.
A Ultravist 300 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ultravist 300, including repackagers and relabelers. The FDA regulates Ultravist 300 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ultravist 300 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ultravist 300 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Ultravist 300 supplier is an individual or a company that provides Ultravist 300 active pharmaceutical ingredient (API) or Ultravist 300 finished formulations upon request. The Ultravist 300 suppliers may include Ultravist 300 API manufacturers, exporters, distributors and traders.
click here to find a list of Ultravist 300 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ultravist 300 Drug Master File in Korea (Ultravist 300 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ultravist 300. The MFDS reviews the Ultravist 300 KDMF as part of the drug registration process and uses the information provided in the Ultravist 300 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ultravist 300 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ultravist 300 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ultravist 300 suppliers with KDMF on PharmaCompass.
We have 1 companies offering Ultravist 300
Get in contact with the supplier of your choice:
